SelectQuote (NYSE:SLQT – Get Free Report) is one of 311 publicly-traded companies in the “Insurance” industry, but how does it compare to its competitors? We will compare SelectQuote to related businesses based on the strength of its valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.
Risk & Volatility
SelectQuote has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500. Comparatively, SelectQuote’s competitors have a beta of -1.59, indicating that their average stock price is 259% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for SelectQuote and its competitors, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SelectQuote | 1 | 2 | 0 | 1 | 2.25 |
| SelectQuote Competitors | 3357 | 15740 | 16585 | 749 | 2.40 |
SelectQuote currently has a consensus target price of $60.00, indicating a potential upside of 811.02%. As a group, “Insurance” companies have a potential upside of 5.37%. Given SelectQuote’s higher possible upside, analysts clearly believe SelectQuote is more favorable than its competitors.
Profitability
This table compares SelectQuote and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SelectQuote | 4.61% | 22.48% | 6.06% |
| SelectQuote Competitors | 9.46% | -10.07% | 4.09% |
Insider and Institutional Ownership
34.6% of SelectQuote shares are owned by institutional investors. Comparatively, 55.8% of shares of all “Insurance” companies are owned by institutional investors. 11.6% of SelectQuote shares are owned by company insiders. Comparatively, 13.5% of shares of all “Insurance” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares SelectQuote and its competitors gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| SelectQuote | $1.62 billion | $62.19 million | -219.53 |
| SelectQuote Competitors | $15.05 billion | $1.70 billion | 32.96 |
SelectQuote’s competitors have higher revenue and earnings than SelectQuote. SelectQuote is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Summary
SelectQuote competitors beat SelectQuote on 8 of the 13 factors compared.
SelectQuote Company Profile
SelectQuote, Inc. operates a direct-to-consumer insurance distribution platform that helps consumers compare coverage from multiple insurance providers. Its licensed agents assist customers with evaluating options and selecting policies. The company offers Medicare-related products, including Medicare Advantage, Medicare Supplement and prescription drug plans, as well as life, auto and home insurance. Its services also include SelectRx, which provides pharmacy and medication-management services.
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.
